These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 14716756

  • 1. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ.
    Fisher ER, Land SR, Fisher B, Mamounas E, Gilarski L, Wolmark N.
    Cancer; 2004 Jan 15; 100(2):238-44. PubMed ID: 14716756
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Adepoju LJ, Symmans WF, Babiera GV, Singletary SE, Arun B, Sneige N, Pusztai L, Buchholz TA, Sahin A, Hunt KK, Meric-Bernstam F, Ross MI, Ames FC, Kuerer HM.
    Cancer; 2006 Jan 01; 106(1):42-50. PubMed ID: 16333852
    [Abstract] [Full Text] [Related]

  • 7. Is there a low-grade precursor pathway in breast cancer?
    King TA, Sakr RA, Muhsen S, Andrade VP, Giri D, Van Zee KJ, Morrow M.
    Ann Surg Oncol; 2012 Apr 01; 19(4):1115-21. PubMed ID: 21935747
    [Abstract] [Full Text] [Related]

  • 8. Factors predicting in-breast tumor recurrence after breast-conserving surgery.
    Mechera R, Viehl CT, Oertli D.
    Breast Cancer Res Treat; 2009 Jul 01; 116(1):171-7. PubMed ID: 18815880
    [Abstract] [Full Text] [Related]

  • 9. Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences.
    Huang E, Buchholz TA, Meric F, Krishnamurthy S, Mirza NQ, Ames FC, Feig BW, Kuerer HM, Ross MI, Singletary SE, McNeese MD, Strom EA, Hunt KK.
    Cancer; 2002 Nov 15; 95(10):2059-67. PubMed ID: 12412158
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Bilateral and multifocal breast carcinoma. A clinical and autopsy study with special emphasis on carcinoma in situ.
    Ringberg A, Palmer B, Linell F, Rychterova V, Ljungberg O.
    Eur J Surg Oncol; 1991 Feb 15; 17(1):20-9. PubMed ID: 1847343
    [Abstract] [Full Text] [Related]

  • 13. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL.
    APMIS Suppl; 2003 Feb 15; (108):1-67. PubMed ID: 12874968
    [Abstract] [Full Text] [Related]

  • 14. Epidemiological survey of preinvasive breast cancer.
    Vandenbroucke A, Bourdon C.
    Eur J Cancer Prev; 1993 Nov 15; 2 Suppl 3():3-10. PubMed ID: 8298449
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Lobular carcinoma in situ (LCIS): pathology and treatment.
    Gump FE.
    J Cell Biochem Suppl; 1993 Nov 15; 17G():53-8. PubMed ID: 8007710
    [Abstract] [Full Text] [Related]

  • 17. Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation.
    Sasson AR, Fowble B, Hanlon AL, Torosian MH, Freedman G, Boraas M, Sigurdson ER, Hoffman JP, Eisenberg BL, Patchefsky A.
    Cancer; 2001 May 15; 91(10):1862-9. PubMed ID: 11346867
    [Abstract] [Full Text] [Related]

  • 18. Concurrent lobular neoplasia increases the risk of ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Rudloff U, Brogi E, Brockway JP, Goldberg JI, Cranor M, Wynveen CA, Nehhozina T, Reiner AS, Patil S, Van Zee KJ.
    Cancer; 2009 Mar 15; 115(6):1203-14. PubMed ID: 19170233
    [Abstract] [Full Text] [Related]

  • 19. Is lobular carcinoma in situ as a component of breast carcinoma a risk factor for local failure after breast-conserving therapy? Results of a matched pair analysis.
    Ben-David MA, Kleer CG, Paramagul C, Griffith KA, Pierce LJ.
    Cancer; 2006 Jan 01; 106(1):28-34. PubMed ID: 16329136
    [Abstract] [Full Text] [Related]

  • 20. The use of molecular assays to establish definitively the clonality of ipsilateral breast tumor recurrences and patterns of in-breast failure in patients with early-stage breast cancer treated with breast-conserving therapy.
    Vicini FA, Antonucci JV, Goldstein N, Wallace M, Kestin L, Krauss D, Kunzmann J, Gilbert S, Schell S.
    Cancer; 2007 Apr 01; 109(7):1264-72. PubMed ID: 17372920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.